Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.1 HKD | -1.12% |
|
-4.08% | -52.84% |
06-03 | ImmuneOnco Biopharmaceuticals Gets China's Phase 3 Trial Approval for Leukemia Drug | MT |
05-30 | ImmuneOnco Completes Filing with China Regulator for Conversion of H Shares | MT |